Researchers at University College London (UCL) report a promising step toward restoring muscle control after motor neuron loss in amyotrophic lateral sclerosis (ALS). In a study documented in the preprint repository eLife Reviewed Preprint, donor-derived motor neurons were transplanted into a mouse model with a very aggressive ALS phenotype. The aim was to reestablish neural connections to affected muscles and improve function, a long-sought goal in ALS research.
ALS is the most common form of motor neuron disease in adults. It disrupts the signals that nerves send to muscles, gradually weakening them and leading to paralysis. Motor neurons normally coordinate movement and maintain muscle tone. When these connections fail, the body loses voluntary control and strength, and progressive disability follows. The prognosis and progression of ALS vary widely among individuals, and no current therapy can fully halt the disease’s course. In the study, scientists used donor motor neurons to replace damaged cells and examined whether integration with the host nervous system could restore meaningful muscle activity.
The researchers worked with a mouse model that mimics many features of human ALS. Healthy motor neurons were introduced into the tibial nerve, a key conduit to lower leg muscles. To prevent the immune system from rejecting the transplanted cells, the team administered the H57-597 antibody, which dampens immune responses. This allowed the graft to survive and form connections with target muscles, though initial contractions remained relatively weak. A critical observation was that transplanted neurons, even when alive, need ongoing stimulation to mature fully and establish robust neuromuscular junctions capable of producing strong muscle force.
To address this challenge, the scientists implemented a wireless stimulation system that delivered light to activate the transplanted neurons. This optogenetic approach was paired with daily sessions of muscle activation, creating a regimen that simulated regular neural drive to the muscles. Over the course of 21 days, the treated muscles showed a remarkable enhancement in strength, with contractions increasing about thirteenfold compared with baseline measurements. The results indicate that combining cell replacement with systematic neural stimulation can significantly boost functional outcomes in this ALS model.
Despite the encouraging results, the researchers emphasize caution when translating these findings to humans. It remains to be determined whether similar transplantation strategies could be safely applied to human neurons, and whether the gains observed in mice would persist in people living with ALS. Additional studies are needed to assess long-term safety, durability of the neural graft, and the extent to which such an approach could improve quality of life for patients. The work contributes to a broader understanding of how transplanted motor neurons might work alongside technologies that modulate neural activity to support motor function in neurodegenerative disease.
These findings add a new layer to the ongoing exploration of regenerative therapies for ALS, a condition that continues to challenge scientists, clinicians, and patients alike. The combination of cell replacement with targeted stimulation demonstrates a potential path toward restoring mobility in people affected by this disease, while also highlighting the careful, stepwise nature of translating animal research into human treatment trials. Ongoing investigations will further clarify how such strategies might be optimized for safety, effectiveness, and accessibility in future clinical settings.
ancient scientists to solveHow to reduce the risk of dementia by 48% in atrial fibrillation.